Recon: Becerra signals more time needed to nominate FDA chief; CureVac vaccine disappoints in pivotal trial
ReconMichael Mezher
BiologicsBiotechnologyCombination ProductsDiagnosticsMedical DevicesPharmaceuticalsReconMichael MezherBiologicsBiotechnologyCombination ProductsDiagnosticsMedical DevicesPharmaceuticals